Doctor’s Passport

Find your next topic

Explore the current textbook

Available drafts · Clinical review pending
Membership
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
Rapid

Carotid stenting concepts

Essential points for quick revision.

Saved on this device
!
Neurological change during or after stenting

Any new focal deficit, reduced consciousness or severe headache after carotid stenting may represent embolic stroke, stent thrombosis, haemorrhage or hyperperfusion.

Action: Activate the stroke and neurovascular emergency pathway immediately, obtain urgent brain and arterial imaging, and control airway and haemodynamics while the intervention team evaluates rescue treatment.

Synopsis

Explain safe selection, preparation, conduct, complications and follow-up of carotid artery stenting in UK adult practice.

  • Carotid stenting is selected through specialist multidisciplinary comparison with endarterectomy; age, timing, arch and lesion anatomy, prior neck treatment, comorbidity and local audited outcomes all matter.
  • For recently symptomatic patients needing revascularisation within fourteen days, endarterectomy is generally preferred over transfemoral stenting because early procedural stroke or death is higher with stenting, especially from age seventy.
  • New deficit, severe headache, seizure, hypertension, bradycardia or hypotension around stenting demands immediate assessment for embolism, thrombosis, haemorrhage, hyperperfusion or haemodynamic instability.

Key red flags

New weakness, aphasia, visual loss or neglect during or after the procedure requires immediate neurological assessment and imaging.

Severe ipsilateral headache, seizure, hypertension or reduced consciousness after revascularisation raises cerebral hyperperfusion and intracranial haemorrhage.

Profound bradycardia or hypotension during ballooning can impair cerebral and coronary perfusion and needs prompt monitored treatment.

Acute neck swelling, stridor or tracheal deviation after transcarotid access threatens the airway and requires immediate surgical review.

Periprocedural cerebral embolism

Abrupt monocular loss, aphasia, neglect or contralateral weakness during wire passage or after deployment suggests thromboembolism or acute stent failure.

Haemodynamic depression

Bradycardia and hypotension during ballooning or after stenting reflect carotid-sinus stimulation and can compromise cerebral or myocardial perfusion.

Hyperperfusion or haemorrhage

New severe headache, seizure, hypertension, focal deficit or reduced consciousness after flow restoration requires urgent brain imaging and blood-pressure treatment.

Investigation priorities

01
Accredited carotid duplex ultrasoundFirst step

Confirm stenosis severity, plaque location and flow while documenting the measurement criteria used.

Management branches

SELECTChoose the revascularisation method

A patient has carotid disease for which revascularisation benefit is being considered.

  1. Confirm that symptoms are ipsilateral and attributable, quantify neurological disability and infarct burden, and verify stenosis with the stated NASCET-equivalent method.
  2. Compare expected benefit with the centre's procedural risk, then weigh age, timing, neck factors, cardiopulmonary risk, arch anatomy and lesion morphology.

Key medicines

AspirinGive 75 to 325 mg orally once daily with clopidogrel for carotid stenting; continue the combination for at least four weeks, then follow the documented long-term single-agent plan.Check hypersensitivity, active bleeding, peptic ulcer risk and concomitant anticoagulation; prolonged dual therapy needs another indication and gastroprotection may be appropriate.
ClopidogrelGive 75 mg orally once daily starting at least three days before CAS, or a single 300 mg oral loading dose in urgent cases; continue with aspirin for at least four weeks, then usually continue 75 mg daily alone long term.Avoid with active pathological bleeding or severe hepatic impairment; review bruising, blood counts and interacting CYP2C19 inhibitors, particularly omeprazole or esomeprazole.
Open full textbook Answer 2 questions
Sources and review status4 sources · checked 12 Sept 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 12 Sept 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom